| 产品详情 |
| Edit |   |
|---|
| Product Name | Tocilizumab (Actemra®) BioAssay™ ELISA Kit |
|---|
| Description | Tocilizumab (Actemra®) is an immunosuppressive humanized monoclonal antibody drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. Tocilizumab binds the interleukin-6 receptor (IL-6R) thus blocking the signaling caused by interleukin 6 (IL-6). IL-6 is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases. Sample Type: Serum and plasma Intended Use: The Tocilizumab ELISA kit is designed to measure free Tocilizumab with high specificity and sensitivity. Sensitivity: 1.5ng/ml Recovery: 250ng/mL of Tocilizumab was spiked in 10 lots of human serum. Recovery ranges are from 88-112% with an average recovery of 104%. Precision: Intra-assay CV: <10% Inter-assay CV: <10%. Specificity: hIgG1, Rituximab, and Infliximab prepared at 250ng/mL were assayed and exhibited no cross-reactivity or interference. Test Principle: This assay employs the sandwich |
|---|
| Size | 96 tests |
|---|
| Concentration | n/a |
|---|
| Applications | ELISA |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 384867 |
|---|
| Price | |
|---|
| Order / More Info | Tocilizumab (Actemra®) BioAssay™ ELISA Kit from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|